94 related articles for article (PubMed ID: 17079211)
1. Calculating risk/benefit in X-linked severe combined immune deficiency disorder (X-SCID) gene therapy trials: the task of ethical evaluation.
Swazo NK
J Med Philos; 2006 Oct; 31(5):533-64. PubMed ID: 17079211
[TBL] [Abstract][Full Text] [Related]
2. The evolution of gene therapy in X-linked severe combined immunodeficiency.
Rans TS; England R
Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
Couzin J; Kaiser J
Science; 2005 Feb; 307(5712):1028. PubMed ID: 15718439
[No Abstract] [Full Text] [Related]
4. [Bioethics: problems and prospects within a research institute].
Guidoni L
Ann Ist Super Sanita; 2004; 40(3):309-15. PubMed ID: 15637405
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for severe combined immune deficiency.
Qasim W; Gaspar HB; Thrasher AJ
Expert Rev Mol Med; 2004 Jul; 6(13):1-15. PubMed ID: 15236670
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
Kaiser J
Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
[No Abstract] [Full Text] [Related]
8. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
[TBL] [Abstract][Full Text] [Related]
9. US authorities uphold suspension of SCID gene therapy.
Fox JL
Nat Biotechnol; 2003 Mar; 21(3):217. PubMed ID: 12610555
[No Abstract] [Full Text] [Related]
10. French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
European Society of Gene Therapy
J Gene Med; 2003 Jan; 5(1):82-4. PubMed ID: 12516054
[No Abstract] [Full Text] [Related]
11. RNA interference: a critical analysis of the regulatory and ethical issues encountered in the development of a novel therapy.
McKnight R
Albany Law J Sci Technol; 2004; 15(1):73-108. PubMed ID: 17340758
[No Abstract] [Full Text] [Related]
12. The long and winding road to clinical success in gene therapy.
Rosenecker J
Curr Opin Mol Ther; 2010 Oct; 12(5):507-8. PubMed ID: 20931738
[No Abstract] [Full Text] [Related]
13. Ethics of cancer gene transfer clinical research.
Kimmelman J
Methods Mol Biol; 2009; 542():423-45. PubMed ID: 19565916
[TBL] [Abstract][Full Text] [Related]
14. National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
Recomb DNA Tech Bull; 1986 Dec; 9(4):221-42. PubMed ID: 3469693
[No Abstract] [Full Text] [Related]
15. Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT).
Gansbacher B;
J Gene Med; 2003 Mar; 5(3):261-2. PubMed ID: 12666192
[No Abstract] [Full Text] [Related]
16. Gene therapy. Second child in French trial is found to have leukemia.
Marshall E
Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
[No Abstract] [Full Text] [Related]
17. Safeguards for gene therapy trials.
FDA Consum; 2003; 37(3):5. PubMed ID: 12793378
[No Abstract] [Full Text] [Related]
18. Cancer fears cast doubts on future of gene therapy.
Check E
Nature; 2003 Feb; 421(6924):678. PubMed ID: 12610583
[No Abstract] [Full Text] [Related]
19. Gene therapy on trial.
Marshall E
Science; 2000 May; 288(5468):951-7. PubMed ID: 10841710
[No Abstract] [Full Text] [Related]
20. [Take-over of the risk-benefit by the clinical study subject and its regulation].
Antal J
Orv Hetil; 2005 Jun; 146(26):1399-404. PubMed ID: 16052982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
